Treatment of Mixed Vulvaginitis in Women with Inflammatory Diseases of the Cervical and Genital

Abstract

Goal: : study of the clinical and laboratory effectiveness of using the drug Klindox (suppositories No. 7, vaginal, containing 100 mg of clotrimazole, tinidazole and clindamycin) for the treatment of vulvovaginitis of mixed etiology in patients with inflammatory diseases of the cervix, as well as the effectiveness of using this drug for the prevention of relapse.

Methods: We examined 41 patients with diseases of the cervix and vulvovaginitis of mixed etiology. It has been established that Klindox (vaginal suppositories containing 100 mg of clotrimazole, tinidazole and clindamycin) can serve as the drug of choice for the treatment and prevention of recurrence of inflammatory diseases, which is highly effective and safe. During the use of the drug, there are no undesirable side reactions, it is able to normalize the indicators of clinical and laboratory examination in 97.6% of cases and improve the condition in this contingent of patients.

Results: During the period 2022-2023, at the Bukhara Regional Medical Diagnostic Center, we examined 41 women who consulted with various gynecological diseases at the age of 20 to 59 years. The age groups were comparable: the average age of patients in the 1st main group was 29.61 ± 1.19 years.